Joint Formulary & PAD

Liraglutide - Weight management in adolescents

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Liraglutide
Indication :
Weight management in adolescents
Group Name :
Keywords :
obesity, overweight, weight loss
Brand Names Include :
Saxenda, Biolide
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Liraglutide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Weight management in adolescents.

Committee Recommendations (1)

The Surrey Heartlands APC does not recommend the use of Liraglutide (Saxenda) for managing obesity in people aged 12 to 17 years.


This decision follows the termination of the NICE appraisal (TA749): Liraglutide for managing obesity in people aged 12 to 17 years.